190 related articles for article (PubMed ID: 26910582)
21. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
Paterson NE; Min W; Hackett A; Lowe D; Hanania T; Caldarone B; Ghavami A
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1455-64. PubMed ID: 20708056
[TBL] [Abstract][Full Text] [Related]
22. Effects of nicotine in combination with drugs described as positive allosteric nicotinic acetylcholine receptor modulators in vitro: discriminative stimulus and hypothermic effects in mice.
Moerke MJ; de Moura FB; Koek W; McMahon LR
Eur J Pharmacol; 2016 Sep; 786():169-178. PubMed ID: 27238974
[TBL] [Abstract][Full Text] [Related]
23. Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice.
Hendrickson LM; Zhao-Shea R; Tapper AR
Psychopharmacology (Berl); 2009 Jul; 204(4):563-72. PubMed ID: 19247637
[TBL] [Abstract][Full Text] [Related]
24. Green tobacco sickness: mecamylamine, varenicline, and nicotine vaccine as clinical research tools and potential therapeutics.
McMahon LR
Expert Rev Clin Pharmacol; 2019 Mar; 12(3):189-195. PubMed ID: 30650314
[TBL] [Abstract][Full Text] [Related]
25. Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
Gould RW; Czoty PW; Nader SH; Nader MA
J Pharmacol Exp Ther; 2011 Nov; 339(2):678-86. PubMed ID: 21856860
[TBL] [Abstract][Full Text] [Related]
26. Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure.
Zambrano CA; Short CA; Salamander RM; Grady SR; Marks MJ
Pharmacol Res Perspect; 2015 Mar; 3(2):e00111. PubMed ID: 25729578
[TBL] [Abstract][Full Text] [Related]
27. Attenuated nicotine-like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine daily.
Cunningham CS; Moerke MJ; Javors MA; Carroll FI; McMahon LR
Br J Pharmacol; 2016 Dec; 173(24):3454-3466. PubMed ID: 27667659
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of Opioid Antinociception by Nicotinic Ligands.
de Moura FB; Bergman J
J Pharmacol Exp Ther; 2021 Apr; 377(1):100-107. PubMed ID: 33441370
[TBL] [Abstract][Full Text] [Related]
29. Patterns of nicotinic receptor antagonism: nicotine discrimination studies.
Jutkiewicz EM; Brooks EA; Kynaston AD; Rice KC; Woods JH
J Pharmacol Exp Ther; 2011 Oct; 339(1):194-202. PubMed ID: 21730011
[TBL] [Abstract][Full Text] [Related]
30. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
Spiller K; Xi ZX; Li X; Ashby CR; Callahan PM; Tehim A; Gardner EL
Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
[TBL] [Abstract][Full Text] [Related]
31. Anti-smoking drugs cytisine and varenicline reduce cardiac reperfusion injury in rat model of myocardial ischemia.
Shaykhutdinova ER; Severyukhina MS; Kholoshenko IV; Gondarenko EA; Shelukhina IV; Kryukova EV; Ismailova AM; Sadovnikova ES; Dyachenko IA; Murashev AN; Tsetlin VI; Utkin YN
Biochimie; 2024 Jan; 216():108-119. PubMed ID: 37871826
[TBL] [Abstract][Full Text] [Related]
32. Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.
Rollema H; Shrikhande A; Ward KM; Tingley FD; Coe JW; O'Neill BT; Tseng E; Wang EQ; Mather RJ; Hurst RS; Williams KE; de Vries M; Cremers T; Bertrand S; Bertrand D
Br J Pharmacol; 2010 May; 160(2):334-45. PubMed ID: 20331614
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
Meyers EE; Loetz EC; Marks MJ
Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
[TBL] [Abstract][Full Text] [Related]
34. Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds.
Desai RI; Bergman J
J Pharmacol Exp Ther; 2010 Dec; 335(3):807-16. PubMed ID: 20847037
[TBL] [Abstract][Full Text] [Related]
35. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
[TBL] [Abstract][Full Text] [Related]
36. Mecamylamine-precipitated nicotine withdrawal syndrome and its prevention with baclofen: an autoradiographic study of α4β2 nicotinic acetylcholine receptors in mice.
Varani AP; Antonelli MC; Balerio GN
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():217-25. PubMed ID: 23500668
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs.
Cippitelli A; Brunori G; Schoch J; Armishaw CJ; Wu J; Zaveri NT; Giulianotti MA; Welmaker GS; Toll L
Psychopharmacology (Berl); 2018 Jun; 235(6):1745-1757. PubMed ID: 29572652
[TBL] [Abstract][Full Text] [Related]
38. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
[TBL] [Abstract][Full Text] [Related]
39. Alpha3beta4-nicotinic receptors mediate adrenergic nerve- and peptidergic (CGRP) nerve-dependent vasodilation induced by nicotine in rat mesenteric arteries.
Eguchi S; Miyashita S; Kitamura Y; Kawasaki H
Br J Pharmacol; 2007 Aug; 151(8):1216-23. PubMed ID: 17572697
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
Khan IM; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 1994 Jul; 270(1):150-8. PubMed ID: 8035311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
